Literature DB >> 19174775

Unintended pregnancy during radiotherapy for cancer.

Saskia N de Wildt1, Nobuko Taguchi, Gideon Koren.   

Abstract

BACKGROUND: A 27-year-old woman with upper mediastinum stage IIA Hodgkin lymphoma was treated with six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy. Two months later she received a total of 4,250 cGy to the upper mediastinum and left clavicular region over a 1-month period. One week after completion of radiotherapy she was found to be 13-weeks pregnant. Her physician advised her to terminate pregnancy. She contacted a teratology information service for further information regarding the risks of radiation exposure for her fetus. INVESTIGATIONS: Estimation of fetal radiation exposure, literature review and synthesis of published cases and effects of fetal radiation exposure. DIAGNOSIS: Estimated fetal radiation dose between 5 and 18 cGy. MANAGEMENT: Counseling on the possible risks to the fetus as a result of radiation exposure.

Entities:  

Mesh:

Year:  2009        PMID: 19174775     DOI: 10.1038/ncponc1320

Source DB:  PubMed          Journal:  Nat Clin Pract Oncol        ISSN: 1743-4254


  12 in total

1.  Radiotherapy of Hodgkin's disease in early pregnancy: embryo dose measurements.

Authors:  Michael Mazonakis; Haris Varveris; Maria Fasoulaki; John Damilakis
Journal:  Radiother Oncol       Date:  2003-03       Impact factor: 6.280

Review 2.  Treatment of Hodgkin lymphoma: the past, present, and future.

Authors:  Andrew M Evens; Martin Hutchings; Volker Diehl
Journal:  Nat Clin Pract Oncol       Date:  2008-09

Review 3.  Risk of childhood cancer from fetal irradiation.

Authors:  R Doll; R Wakeford
Journal:  Br J Radiol       Date:  1997-02       Impact factor: 3.039

Review 4.  Fetal outcome after maternal radiation treatment of supradiaphragmatic Hodgkin's disease.

Authors:  E Friedman; G W Jones
Journal:  CMAJ       Date:  1993-11-01       Impact factor: 8.262

Review 5.  Non-Hodgkin's lymphoma and pregnancy.

Authors:  M Lishner; D Zemlickis; S B Sutcliffe; G Koren
Journal:  Leuk Lymphoma       Date:  1994-08

Review 6.  Radiotherapy during pregnancy: fact and fiction.

Authors:  Henk B Kal; Henk Struikmans
Journal:  Lancet Oncol       Date:  2005-05       Impact factor: 41.316

7.  A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Brain damage among the prenatally exposed.

Authors:  M Otake; W J Schull; H Yoshimaru
Journal:  J Radiat Res       Date:  1991-03       Impact factor: 2.724

8.  Biological effects after prenatal irradiation (embryo and fetus). A report of the International Commission on Radiological Protection.

Authors:  C Streffer; R Shore; G Konermann; A Meadows; P Uma Devi; J Preston Withers; L-E Holm; J Stather; K Mabuchi
Journal:  Ann ICRP       Date:  2003

Review 9.  Neurodevelopment of children exposed in utero to treatment of maternal malignancy.

Authors:  I Nulman; D Laslo; S Fried; E Uleryk; M Lishner; G Koren
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

10.  Maternal and foetal outcome following Hodgkin's disease in pregnancy.

Authors:  M Lishner; D Zemlickis; P Degendorfer; T Panzarella; S B Sutcliffe; G Koren
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more
  3 in total

1.  In utero exposure to therapeutic radiation for Hodgkin lymphoma.

Authors:  Chagit Klieger-Grossmann; Nada Djokanovic; David Chitayat; Gideon Koren
Journal:  Can Fam Physician       Date:  2009-10       Impact factor: 3.275

Review 2.  Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review.

Authors:  M R Boland; N P Tatonetti
Journal:  Pharmacogenomics J       Date:  2016-07-12       Impact factor: 3.550

3.  Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept.

Authors:  Miriam G Mooij; Esther van Duijn; Catherijne A J Knibbe; Albert D Windhorst; N Harry Hendrikse; Wouter H J Vaes; Edwin Spaans; Babs O Fabriek; Hugo Sandman; Dimitri Grossouw; Lidwien M Hanff; Paul J J M Janssen; Birgit C P Koch; Dick Tibboel; Saskia N de Wildt
Journal:  Clin Pharmacokinet       Date:  2014-11       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.